BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 11, 2011
View Archived Issues
Novartis presents key developments of third quarter 2011
Read More
Phase II data on FG-4592 presented at Kidney Week
Read More
Phase IIa trial assesses systemic ammonia scavenger in liver disease
Read More
Fixed doses selected for further phase II sifalimumab testing in SLE
Read More
Analyses highlight importance of patient selection for diabetic nephropathy therapy
Read More
XOMA broadens phase III program for gevokizumab
Read More
Verona Pharma's RPL-554 demonstrates bronchodilation in phase IIa study
Read More
Data reported on immunotherapy for use in liver transplantation for chronic hepatitis C
Read More
Merck & Co. discloses new protein kinase inhibitors
Read More
Novel glutaminyl-peptide cyclotransferase inhibitors synthesized by Probiodrug
Read More
SymBio begins Japanese phase II trial of SyB L-0501 for new indication
Read More
Boehringer Ingelheim presents novel PDK1 inhibitors
Read More
Seikagaku to begin phase III study of enzyme therapy in lumbar disc herniation
Read More
New cytochrome P450 19A1 inhibitors patented in U.S.
Read More
Daiichi Sankyo licenses protein kinase inhibitor from ArQule for phase I development
Read More
Phase I and II studies commence for BMS-927711 in migraine
Read More
Canadian organization prepares novel protein kinase inhibitors
Read More
Lundbeck and Otsuka collaborate on products for psychiatric conditions
Read More
Japanese encephalitis vaccine approved in India
Read More
NeuroDerm reports phase II ND-0611 data
Read More
BioDelivery Sciences begins dose-finding BNX-102 study
Read More
FDA releases safety communication on Trilipix
Read More
Anacor advances phase III AN-2690 study
Read More
FDA grants orphan drug status to Santen product in noninfectious uveitis
Read More
Napo cites breach of contract in termination of agreement with Salix
Read More
Dosing complete in phase II trial of ASP-7373
Read More